Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.
Arbeitsgruppe für Anwendung von künstlicher Intelligenz und digitalen Gesundheits-anwendungen in der Urologie, Klinikum der Universität München, Munich, Germany.
Urol Int. 2021;105(7-8):650-656. doi: 10.1159/000515982. Epub 2021 May 5.
There are limited data on the use and concern of telemedicine among German urologists, and thus, there are no established guidelines for telemedical diagnosis, treatment, and prevention of urological indications.
An anonymized survey was conducted among German private practice urologists during the 2019 coronavirus disease (COVID-19) pandemic. The χ2 test, Mann-Whitney U-test, and Kruskal-Wallis test were used for statistical analysis.
257 urologists were included in the final analysis. Thirty-five (14.0%) of urologists had used telemedicine as part of their consultation, and 221 (86.0%) had not used telemedicine. There was no difference between telemedicine adoption rates between rural and urban settings. Telemedicine users were significantly more satisfied with the information they had received regarding telemedicine issues. Users saw the greatest barrier to telemedicine that patients do not take up the offer of telemedicine. Nonusers were most concerned with unclear indications for telemedicine followed by lesser reimbursements during telemedicine than in-person visitations. Users were significantly more likely to use telemedicine beyond the COVID-19 pandemic. Urologists, who wanted to use the service in the future, wanted an active support by the German society of urology and guidelines for telemedicine. Last, users and nonusers preferred telemedicine for non-acute chronic diseases and follow-up visitations.
Despite the COVID-19 pandemic, telemedicine remains a rarely used service among German private practice urologists. Ultimately, to overcome the current challenges, urologists require an active support for the service through the German Society of Urology and telemedical guidelines.
德国泌尿科医生在使用和关注远程医疗方面的数据有限，因此，目前还没有针对远程医疗诊断、治疗和预防泌尿科疾病的既定指南。
在 2019 年冠状病毒病（COVID-19）大流行期间，对德国私人执业泌尿科医生进行了匿名调查。使用卡方检验、Mann-Whitney U 检验和 Kruskal-Wallis 检验进行统计学分析。
最终纳入 257 名泌尿科医生进行分析。35 名（14.0%）泌尿科医生曾将远程医疗作为其咨询的一部分，221 名（86.0%）未使用远程医疗。城乡地区远程医疗的采用率没有差异。使用远程医疗的医生对他们收到的关于远程医疗问题的信息满意度更高。使用者认为患者不接受远程医疗服务是远程医疗的最大障碍。非使用者最关心远程医疗的指征不明确，其次是远程医疗的报销比面对面就诊少。使用者更有可能在 COVID-19 大流行后继续使用远程医疗。未来希望使用该服务的泌尿科医生希望德国泌尿科协会为其提供积极支持并制定远程医疗指南。最后，使用者和非使用者更喜欢将远程医疗用于非急性慢性疾病和随访就诊。
尽管 COVID-19 大流行，远程医疗在德国私人执业泌尿科医生中仍然很少使用。最终，为了克服当前的挑战，泌尿科医生需要德国泌尿科协会通过服务和远程医疗指南提供积极支持。
